No abstract available
Plain language summary
This cross-sectional study examines and compares the time taken from the accelerated approval of cancer and noncancer drugs to the initiation of confirmatory studies in the US.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents* / therapeutic use
-
Drug Approval
-
Humans
-
Neoplasms* / drug therapy
-
United States
-
United States Food and Drug Administration